Genpharmasec Ltd 22 May 2026 12:00 AM
Genpharmasec reports consolidated net profit of Rs 1.23 crore in the March 2026 quarter,
Net profit of Genpharmasec reported to Rs 1.23 crore in the quarter ended March 2026 as against net loss of Rs 0.27 crore during the previous quarter ended March 2025. Sales rose 295.65% to Rs 55.43 crore in the quarter ended March 2026 as against Rs 14.01 crore during the previous quarter ended March 2025.For the full year,net profit rose 2.56% to Rs 1.60 crore in the year ended March 2026 as against Rs 1.56 crore during the previous year ended March 2025. Sales rose 315.01% to Rs 139.94 crore in the year ended March 2026 as against Rs 33.72 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales55.4314.01 296 139.9433.72 315 OPM %3.59-7.14 -0.871.19 - PBDT2.53-0.17 LP 3.143.02 4 PBT1.85-0.43 LP 0.972.21 -56 NP1.23-0.27 LP 1.601.56 3 Powered by Capital Market - Live News
Genpharmasec Ltd 13 May 2026 12:00 AM
Genpharmasec to hold board meeting,
Genpharmasec will hold a meeting of the Board of Directors of the Company on 21 May 2026.
Genpharmasec Ltd 09 Feb 2026 12:00 AM
Genpharmasec reports consolidated net loss of Rs 0.83 crore in the December 2025 quarter,
Net loss of Genpharmasec reported to Rs 0.83 crore in the quarter ended December 2025 as against net profit of Rs 0.76 crore during the previous quarter ended December 2024. Sales rose 369.69% to Rs 39.83 crore in the quarter ended December 2025 as against Rs 8.48 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales39.838.48 370 OPM %-3.118.37 - PBDT-0.671.37 PL PBT-1.331.27 PL NP-0.830.76 PL Powered by Capital Market - Live News
Genpharmasec Ltd 02 Feb 2026 12:00 AM
Genpharmasec to discuss results,
Genpharmasec will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News
Genpharmasec Ltd 08 Nov 2025 12:00 AM
Genpharmasec reports consolidated net loss of Rs 1.18 crore in the September 2025 quarter,
Net loss of Genpharmasec reported to Rs 1.18 crore in the quarter ended September 2025 as against net profit of Rs 0.70 crore during the previous quarter ended September 2024. Sales rose 441.29% to Rs 32.64 crore in the quarter ended September 2025 as against Rs 6.03 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales32.646.03 441 OPM %-1.441.99 - PBDT-0.230.81 PL PBT-0.800.50 PL NP-1.180.70 PL Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now